These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3576860)

  • 1. [Topical BCG therapy of in situ cancer of the urinary bladder].
    Mack D; Jakse G
    Urologe A; 1987 Jan; 26(1):22-5. PubMed ID: 3576860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravesical immunotherapy of in situ carcinoma of the urinary bladder using Bacillus Calmette-Guerin (BCG)].
    Jakse G
    Wien Klin Wochenschr; 1987 Feb; 99(4):114-8. PubMed ID: 3577186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lower toxicity with the topical low-dose BCG therapy of superficial bladder carcinoma?].
    Mack D; Frick J
    Urologe A; 1992 Mar; 31(2):88-90. PubMed ID: 1561732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of superficial tumors and carcinomas in situ of the bladder by intravesical BCG therapy].
    Steg A; Leleu C; Boccon-Gibod L; Debré B
    Ann Urol (Paris); 1986; 20(1):26-32. PubMed ID: 3707074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravesical BCG therapy in patients with recurrent superficial bladder tumors].
    Sugimoto M; Yamamoto H; Itakura H; Shinohara M; Kinoshita K
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3725-8. PubMed ID: 2596855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical BCG therapy in patients with superficial bladder tumors.
    Steg A; Belas M; Leleu C; Boccon-Gibod L
    Prog Clin Biol Res; 1989; 310():153-60. PubMed ID: 2771990
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
    Rintala E; Jauhiainen K; Alfthan O
    Prog Clin Biol Res; 1989; 310():271-4. PubMed ID: 2505270
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of Tice strain BCG treatment in patients with transitional cell carcinoma in situ.
    Brosman S
    Prog Clin Biol Res; 1989; 310():193-205. PubMed ID: 2771993
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravesical administration of bacillus Calmette-Guérin in patients with recurrent superficial carcinoma of the urinary bladder: report of a prospective, randomized trial.
    Pinsky CM; Camacho FJ; Kerr D; Geller NL; Klein FA; Herr HA; Whitmore WF; Oettgen HF
    Cancer Treat Rep; 1985 Jan; 69(1):47-53. PubMed ID: 3881177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of carcinoma in situ of the urinary bladder with BCG].
    Schnyder von Wartensee M; Ackermann D; Studer UE; Zingg EJ
    Helv Chir Acta; 1989 Aug; 56(3):351-4. PubMed ID: 2807965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group].
    Nishino Y; Yasuda M; Yokoi S; Ehara H; Yamamoto N; Takahashi Y; Ishihara S; Deguchi T; Kawada Y; Takeda A; Sakai S; Takeuchi T; Taniguchi M; Minoshima K; Hamamoto Y; Kanimoto Y; Nakano M; Fujihiro S; Nezasa S; Matsuda T; Nagatani Y; Maeda S; Tamaki M; Saito A; Komeda H
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1869-73. PubMed ID: 10560414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of superficial transitional cell carcinoma of the bladder.
    Fleischmann J; Goldberg G
    Semin Urol; 1993 Nov; 11(4):193-204. PubMed ID: 8290825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical guide to the use of intravesical BCG for the management of stage Ta, T1, CIS, transitional cell cancer.
    Brosman SA; Lamm DL; van der Meijden AP; Debruyne FM
    Prog Clin Biol Res; 1989; 310():311-23. PubMed ID: 2672019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of intravesical bacillus Calmette-Guérin (BCG) Tice strain on flat carcinoma in situ of the bladder.
    Reitsma DJ; Guinan P; Lamm DL; Khanna OP; Brosma SA; DeKernion JB; Williams RD; Sipmson G; Hanna MG
    Prog Clin Biol Res; 1989; 310():171-85. PubMed ID: 2672014
    [No Abstract]   [Full Text] [Related]  

  • 17. Multicenter study of the BCG Tokyo strain for intravesical treatment in patients with superficial bladder cancer. BCG Study Group.
    Aso Y; Akaza H; Kameyama S; Niijima T
    Prog Clin Biol Res; 1989; 303():383-91. PubMed ID: 2675000
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of superficial tumors of the bladder with bacillus Calmette-Guérin].
    Ackermann D; Schnyder M; Bandelier D; Studer UE
    J Urol (Paris); 1986; 92(1):33-8. PubMed ID: 3722851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Granulomatous prostatitis after intravesical BCG immunotherapy of superficial bladder cancer: a case report].
    Sai S; Sakakibara T; Takashi M; Sakata T; Miyake K
    Hinyokika Kiyo; 1990 Aug; 36(8):953-5. PubMed ID: 2239600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical instillation of BCG in carcinoma in situ of the urinary bladder. EORTC protocol 30861. EORTC-GU Group.
    Jakse G
    Prog Clin Biol Res; 1989; 310():187-92. PubMed ID: 2771992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.